Galactosemia: A Korean Patient and Literature Review

갈락토스 혈증: 한국인 갈락토스 환자 증례보고와 문헌 고찰

  • Yu, Seung Woo (Department of Pediatrics, Chungnam National University Hospital, College of Medicine, Chungnam National University) ;
  • Gang, Mi Hyeon (Department of Pediatrics, Chungnam National University Hospital, College of Medicine, Chungnam National University) ;
  • Lee, Yong Wook (Department of Pediatrics, Chungnam National University Hospital, College of Medicine, Chungnam National University) ;
  • Chang, Mea Young (Department of Pediatrics, Chungnam National University Hospital, College of Medicine, Chungnam National University) ;
  • Levy, Harvey L. (Division of Genetics and Genomics, Children's Hospital, Harvard Medical School) ;
  • Kim, Sook Za (Department of Pediatrics, Chungnam National University Hospital, College of Medicine, Chungnam National University)
  • 유승우 (충남대학교 의과대학 부속병원 소아청소년과) ;
  • 강미현 (충남대학교 의과대학 부속병원 소아청소년과) ;
  • 이용욱 (충남대학교 의과대학 부속병원 소아청소년과) ;
  • 장미영 (충남대학교 의과대학 부속병원 소아청소년과) ;
  • ;
  • 김숙자 (충남대학교 의과대학 부속병원 소아청소년과)
  • Published : 2020.06.30

Abstract

Classic galactosemia is a rare genetic disorder in Korea and the mutation spectrum in Koreans differs from that of Caucasians and non-Caucasian Americans. Classic galactosemia is considered a metabolic complication that is preventable by early detection via newborn screening and dietary treatment. In this most recent case of Korean galactosemia, the patient showed early initiation of clinical symptoms, which manifested during the neonatal period. The patient achieved normalization via diet management to correct metabolic complications. In addition, we assessed the characteristics of mutations in 25 Korean galactosemia cases via a literature review of studies associated with classic galactosemia.

고전적 갈락토스 혈증은 한국에서 드물게 발생하는 유전 대사 질환이다. 또한 한국인의 돌연변이 스펙트럼은 코카시안과 비코카시안의 돌연변이 스펙트럼이 다르다. 한국에서 고전적 갈락토스 혈증은 임상적으로 서방국가와 유사하지만 분자적 연구에 따르면 백인, 아프리카인, 미국인, 일본인 및 한국인에게 고유한 돌연변이가 나타났다. 고전적인 갈락토스 혈증은 신생아 스크리닝 검사로 조기 발견하여 식이요법을 할 경우 대사질환으로 인한 합병증이 예방될 수 있다고 생각되어 왔다. 한국의 고전적 갈락토스 혈증의 가장 최근의 사례에서 신생아 시기에 임상 증상이 시작되었다. 식이 치료를 통하여 합병증이 교정되어 정상화 되었다. 추가로 저자들은 25명의 고전적 갈락토스 혈증을 가진 돌연변이의 특징을 리뷰했다.

Keywords

References

  1. Bosch AM. Classical galactosemia revisited. J Inherit Metab Dis 2006;29:516-25. https://doi.org/10.1007/s10545-006-0382-0
  2. Berry GT. Classic galactosemia and clinical variant galactosemia. $GeneReviews^{(R)}$ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. 2000 Feb 4 [updated 2017 Mar 9].
  3. Gort L, Boleda MD, Tyfield L, Vilarinho L, Rivera I, Cardoso ML, et al. Mutational spectrum of classical galactosaemia in Spain and Portugal. J Inherit Metab Dis 2006;29:739-42. https://doi.org/10.1007/s10545-006-0356-2
  4. Tyfield L, Reichardt J, Fridovich-Keil J, Croke DT, Elsas LJ, Strobl W, et al. Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat. 1999;13:417-30. https://doi.org/10.1002/(SICI)1098-1004(1999)13:6<417::AID-HUMU1>3.0.CO;2-0
  5. Lai K, Langley SD, Singh RH, Dembure PP, Hjelm LN, Elsa, LJ. A prevalent mutation for galactosemia among black Americans. J Pediatr. 1996;128:89-95. https://doi.org/10.1016/S0022-3476(96)70432-8
  6. Hirokawa H, Okano Y, Asada M, Fujimoto A, Suyama I, Isshiki G. Molecular basis for phenotypic heterogeneity in galactosaemia: prediction of clinical phenotype from genotype in Japanese patients. Eur J Hum Genet 1999;7:757-64. https://doi.org/10.1038/sj/ejhg/5200368
  7. Ashino J, Okano Y, Suyama I, Yamazaki T, Yoshino M, Furuyama J, et al. Molecular characterization of galactosemia (type 1) mutations in Japanese. Hum Mutat 1995;6:36-43. https://doi.org/10.1002/humu.1380060108
  8. Lee BH, Cheon CK, Kim JM, Kang M, Kim JH, Yang SH, et al. Low prevalence of classical galactosemia in Korean population. J Hum Genet 2011;56:94-6. https://doi.org/10.1038/jhg.2010.152
  9. Choi R, Jo KI, Ko DH, Lee DH, Song J, Jin DK, et al. Novel GALT variations and mutation spectrum in the Korean population with decreased galactose-1-phosphate uridyltransferase activity. BMC Med Genet 2014;15:94. https://doi.org/10.1186/s12881-014-0094-5
  10. Young BS. Diagnostic algorithm of newborn screening for galactosemia. J Korean Soc Inher Metab Dis 2015;15:101-9.
  11. Cheon CK, Cho MS, Ko JM, Kim GH, Yoo HW. A case of classical galactosemia caused by compound heterozygous mutations of the GALT gene. J Genet Med 2008;5:131-5.
  12. Lafleur JP, Senkbeil S, Novotny J, Nys G, Bogelund N, Rand KD, et al. Rapid and simple preparation of thiol-ene emulsion-templated monoliths and their application as enzymatic microreactors. Lab Chip 2015;15:2162-72. https://doi.org/10.1039/c5lc00224a
  13. Adam BW, Flores SR, Hou Y, Allen TW, De Jesus VR. Galactose-1-phosphate uridyltransferase dried blood spot quality control materials for newborn screening tests. Clin Biochem 2015;48:437-42. https://doi.org/10.1016/j.clinbiochem.2014.12.009
  14. Palmieri M, Mazur A, Berry GT, Ning C, Wehrli S, Yager C, et al. Urine and plasma galactitol in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia. Metabolism 1999;48:1294-302. https://doi.org/10.1016/S0026-0495(99)90271-8
  15. Sanger F, Coulson AR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 1975;94:441-8. https://doi.org/10.1016/0022-2836(75)90213-2
  16. Holton JB, Walter JH, Tyfield LA. Galactosemia. In: Stansbury J, Wyngarden J, Fredrickson D, Goldstein JL, Brown US, editors. 8th ed. New York: McGraw Hill, 1992;1553-85.
  17. Segal S, Berry GT. Disorder of galactose metabolism. In: Stansbury J, Wyngarden J, Fredrickson D, Goldstein JL, Brown US, editors. 7th ed. New York: McGraw Hill, 1990;967-90.
  18. Levy HL, Sepe SJ, Shih VE, Vawter GF, Klein JO. Sepsis due to Escherichia coli in neonates with galactosemia. N Engl J Med 1977;297:823-5. https://doi.org/10.1056/NEJM197710132971510
  19. Park IS, Cho HJ, Lee DH, Song JH. Galactosemia detected by neonatal screening test. J Korean Pediatr Soc 2003;46:440-6.
  20. Jama M, Nelson L, Mao R, Lyon E. Simultaneous Amplification, Detection, and Analysis of Common Mutations in the Galactose-1-Phosphate Uridyl Transferase Gene. J Mol Diagn 2007;9:618-23. https://doi.org/10.2353/jmoldx.2007.070027
  21. Waggoner DD, Buist NRM, Donnell GN. Long-term prognosis in galactosemia: Results of a survey of 350 cases. J Inherit Metab Dis 1999;13:802. https://doi.org/10.1007/BF01800204
  22. Bosch AM. Classic galactosemia: dietary dilemmas. J Inherit Metab Dis 2011;34:257-60. https://doi.org/10.1007/s10545-010-9157-8
  23. Berry GT, Leslie N, Reynolds R, Yager CT, Segal S. Evidence for alternate galactose oxidation in a patient with deletion of the galactose-1-phosphate uridyltransferase gene. Mol Genet Metab 2001;72:316-21. https://doi.org/10.1006/mgme.2001.3151
  24. Schadewaldt P, Hammen H-W, Stolpmann S, Kamalanathan L, Wendel U. Galactonate determination in urine by stable isotope dilution gas chromatographymass spectrometry. J Chromatogr B 2004;801:249-55. https://doi.org/10.1016/j.jchromb.2003.11.020